$0.930000
-0.06-5.97%
Pre-Market: 7:38 AM EDT
15 minutes delayed
Comments
Loading...
Xilio Therapeutics
XLONASDAQ
Xilio Therapeutics (NASDAQ:XLO) Stock, Earnings Estimates, EPS, And Revenue
Xilio Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 12
EPS Estimate
$-0.230
Quarterly Revenue Estimate
$30M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Xilio Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XLO | Xilio Therapeutics | -$0.70 | -$0.23 | — | — | $0.00 | $30.00M | — | — | 08/12/2024 | Get Alert |
| XLO | Xilio Therapeutics | -$0.83 | -$0.11 | -$0.59 | -436.36% | $0.00 | $30.00M | $0.00 | -100.00% | 05/14/2024 | Get Alert |
| XLO | Xilio Therapeutics | -$0.82 | -$0.74 | -$0.64 | 13.51% | $0.00 | — | $0.00 | — | 04/01/2024 | Get Alert |
| XLO | Xilio Therapeutics | -$0.72 | -$0.81 | -$0.61 | 24.69% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| XLO | Xilio Therapeutics | -$0.90 | -$0.87 | -$0.70 | 19.54% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
| XLO | Xilio Therapeutics | -$0.78 | -$0.89 | -$0.83 | 6.74% | $0.00 | — | $0.00 | — | 05/09/2023 | Get Alert |
| XLO | Xilio Therapeutics | -$0.98 | -$0.78 | -$0.82 | -5.13% | $0.00 | — | $0.00 | — | 03/02/2023 | Get Alert |
| XLO | Xilio Therapeutics | -$21.27 | -$0.88 | -$0.72 | 18.18% | $0.00 | — | $0.00 | — | 11/09/2022 | Get Alert |
| XLO | Xilio Therapeutics | -$31.48 | — | -$0.90 | — | $0.00 | — | $0.00 | — | 08/09/2022 | Get Alert |
| XLO | Xilio Therapeutics | -$23.53 | — | -$0.78 | — | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| XLO | Xilio Therapeutics | -$31.51 | -$1.17 | -$0.98 | 16.24% | $0.00 | — | $0.00 | — | 03/01/2022 | Get Alert |
| XLO | Xilio Therapeutics | -$24.19 | -$1.60 | -$21.27 | -1229.37% | $0.00 | — | $0.00 | — | 12/02/2021 | Get Alert |
Xilio Therapeutics (XLO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-14 | $-0.59 | $-0.11 | -436.4 % |
| Mar 2024 | 2024-04-01 | $-0.64 | $-0.74 | 13.5 % |
| Sep 2023 | 2023-11-09 | $-0.61 | $-0.81 | 24.7 % |
| Jun 2023 | 2023-08-14 | $-0.70 | $-0.87 | 19.5 % |
Xilio Therapeutics (XLO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-14 | $0 | $30.00M | -100.0 % |
FAQ
When is Xilio Therapeutics (NASDAQ:XLO) reporting earnings?
Xilio Therapeutics (XLO) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Xilio Therapeutics (NASDAQ:XLO)?
The Actual EPS was $-0.59, which missed the estimate of $-0.11.
What were Xilio Therapeutics’s (NASDAQ:XLO) revenues?
The Actual Revenue was $0K, which missed the estimate of $30M.
Browse earnings estimates, EPS, and revenue on all stocks.